FDA Provides 2020 Rheumatology Drug Update
Emergency Use Approved for Baricitinib with Remdesivir Combination Therapy for SARS-CoV-2
FDA Warning: Avoid Use of NSAIDs after Week 20 of Pregnancy
FDA Approves Tofacitinib for Young Patients with Active Polyarticular JIA
FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction
FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution
U.S. & E.U. Differ on Filgotinib for RA
Guselkumab Approved for PsA
FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 27
- Next Page »